DB
BVS icon

Dmitry Balyasny’s Bioventus BVS Stock Holding History

Dmitry Balyasny’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,797
Closed -$254K – 3034
2026
Q1 		$254K Buy
27,797
+9,130
+49% +$76.6K ﹤0.01% 2620
2025
Q4 		$139K Buy
+18,667
New +$134K ﹤0.01% 2931
2025
Q2 		– Sell
-31,415
Closed -$287K – 2858
2025
Q1 		$287K Buy
31,415
+18,764
+148% +$187K ﹤0.01% 2465
2024
Q4 		$133K Buy
+12,651
New +$150K ﹤0.01% 2583
2024
Q2 		– Sell
-53,696
Closed -$279K – 2609
2024
Q1 		$279K Sell
53,696
-33,212
-38% -$162K ﹤0.01% 2288
2023
Q4 		$458K Buy
+86,908
New +$344K ﹤0.01% 1988
2023
Q3 		– Sell
-406,918
Closed -$1.18M – 2282
2023
Q2 		$1.18M Buy
+406,918
New +$781K ﹤0.01% 1559
2021
Q4 		– Sell
-12,909
Closed -$183K – 2261
2021
Q3 		$183K Buy
+12,909
New +$199K ﹤0.01% 1654

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dmitry Balyasny's BVS Position: Q2 2026 in Review

Dmitry Balyasny sold out of Bioventus (BVS) in Q2 2026, closing a stake of 27,797 shares — an estimated $254K sold.

Dmitry Balyasny first reported a position in BVS in Q3 2021 and held it in 8 quarters. The position peaked at $1.18M in Q2 2023. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Dmitry Balyasny reported no remaining Bioventus position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 27,797 Bioventus shares in Q2 2026, an estimated $254K.
  • Dmitry Balyasny first reported a position in Bioventus in Q3 2021 and held it in 8 quarters.
  • Dmitry Balyasny's Bioventus position peaked at $1.18M in Q2 2023.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.